{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:06:47Z","timestamp":1742807207853,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00280-023-04593-w","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T14:02:06Z","timestamp":1695736926000},"page":"265-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2896-7737","authenticated-orcid":false,"given":"Hajime","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikari","family":"Taka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Yamana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"issue":"5","key":"4593_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ijc.30531","volume":"140","author":"M Hortlund","year":"2017","unstructured":"Hortlund M, Arroyo Muhr LS, Storm H et al (2017) Cancer risks after solid organ transplantation and after long-term dialysis. Int J Cancer 140(5):1091\u20131101","journal-title":"Int J Cancer"},{"issue":"7","key":"4593_CR2","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1111\/cas.14933","volume":"112","author":"H Yasuda","year":"2021","unstructured":"Yasuda H, Yasuda M, Komatsu N (2021) Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: a comprehensive review. Cancer Sci 112(7):2607\u20132624","journal-title":"Cancer Sci"},{"issue":"3","key":"4593_CR3","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/bcp.12988","volume":"82","author":"B Zhao","year":"2016","unstructured":"Zhao B, Chen R, O\u2019Connor OA et al (2016) Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment. Br J Clin Pharmacol 82(3):696\u2013705","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"4593_CR4","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/j.clml.2019.07.443","volume":"19","author":"L Nanni","year":"2019","unstructured":"Nanni L, Pellegrini C, Stefoni V et al (2019) Successful employment of brentuximab vedotin in a patient undergoing hemodialysis: the first real-life experience. Clin Lymphoma Myeloma Leuk 19(11):e595\u2013e596","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"4593_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/jjco\/hyaa169","volume":"51","author":"T Kinoshita","year":"2021","unstructured":"Kinoshita T, Hatake K, Yamamoto K et al (2021) Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed\/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study. Jpn J Clin Oncol 51(1):70\u201377","journal-title":"Jpn J Clin Oncol"},{"issue":"15","key":"4593_CR6","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.3390\/molecules24152754","volume":"24","author":"MH Park","year":"2019","unstructured":"Park MH, Lee BI, Byeon JJ et al (2019) Pharmacokinetic and metabolism studies of monomethyl Auristatin F via liquid chromatography-quadrupole-time-of-flight mass spectrometry. Molecules 24(15):2754","journal-title":"Molecules"},{"issue":"6","key":"4593_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/jcm10061332","volume":"10","author":"HP Chang","year":"2021","unstructured":"Chang HP, Cheung YK, Shah DK (2021) Whole-body pharmacokinetics and physiologically based pharmacokinetic Model for Monomethyl Auristatin E (MMAE). J Clin Med 10(6):1332","journal-title":"J Clin Med"},{"issue":"11","key":"4593_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.clml.2022.07.008","volume":"22","author":"H Yasuda","year":"2022","unstructured":"Yasuda H, Komatsu N, Ando J, Ando M (2022) Hodgkin lymphoma on hemodialysis: a review of treatment and recommendations. Clin Lymphoma Myeloma Leuk 22(11):805\u2013811","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-023-04593-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-023-04593-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-023-04593-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T02:07:19Z","timestamp":1709172439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-023-04593-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["4593"],"URL":"https:\/\/doi.org\/10.1007\/s00280-023-04593-w","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have stated that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki, was approved by the institutional ethics committee of Juntendo University School of Medicine (IRB#E22-0327), and written informed consent was obtained from the patient for publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for publication of this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}